Spero Therapeutics (SPRO) Q3 2024 Earnings

5AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.38
0.07
0.51
0.96

Details

Expected EPS
-0.38
Actual EPS
-0.33
Surprise EPS
0.05
Surprise Percent
+13.16%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.33 per share for Q3 2024.

0 Comments

Share your thoughts